Category Archives: BioEngineering

Zacks #5 Rank Additions for Thursday

Quotes delayed, except where indicated otherwise. Delay times are 15 mins for NASDAQ, NYSE and Amex. See also delay times for other exchanges. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , | Comments Off

Neonatal monitor 'Babalung' could save preemies

The battery-powered apnea monitor alerts caregivers if a newborn stops breathing. Bioengineering students at Rice University have designed a $25 sleep apnea detector they hope to test on premature babies in developing countries this summer. The students hope their bike light alarm will alert caregivers when an infant has stopped breathing. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , | Comments Off

American Oriental Bioengineering Gets NYSE Non-compliance Notice

American Oriental Bioengineering Gets NYSE Non-compliance NoticeSource:http://news.search.yahoo.com/news/rss?p=bioengineering&ei=UTF-8&fl=0&x=wrt

Posted in BioEngineering, Biotechnology | Comments Off

Binghamton Restaurant Week in tweets and pictures

VESTAL —The sixth annual Binghamton University I’m a Complex Kid! (ICK!) Bioengineering… – 12:52 pm Continue reading

Posted in BioEngineering | Tagged , , , , | Comments Off

DNA2.0 Introduces the GPS Bioengineering Platform

New Patent Fortifies the Company’s GeneGPS™ Technology for Protein ExpressionMenlo Park, Calif. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , , , | Comments Off

Turning kitchen gadgets (and more) into low-cost lab equipment

Replacing the Osterizer as standard lab equipment By Kate Rix Lina Nilsson, Tekla Labs founder. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , | Comments Off

The Hertz Foundation Nears Half-Century Milestone; Selects 50th Cadre of Hertz Fellows; Quarter Million Dollar Support …

LIVERMORE, Calif., March 22, 2012 /PRNewswire/ — The Fannie and John Hertz Foundation today announced its 2012 Hertz Fellows. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , | Comments Off

Elmer Gaden Jr., U.Va. biochemical engineering professor, dies at 88

Credit: Elmer Lewis Gaden Jr. In 2009, Elmer Lewis Gaden Jr. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , | Comments Off

Literary: Focusing on graphic novels, fantasy and horror stories

Road to Peace (means abolishing war) The Forum of Questioning Minds presents a lecture from Andy Schoenberg, professor of bioengineering and rehab medicine at the University of Utah. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , | Comments Off

American Oriental Bioengineering Inc. Announces Delay in Filing of its Annual Report on Form 10-K for 2011

NEWARK,N.J., March 16, 2012 /PRNewswire-Asia-FirstCall/ — American Oriental Bioengineering, Inc. (NYSE: AOB – News) (the “Company”), today announced that its Annual Report on Form 10-K for the fiscal year ended December 31, 2011, which was due on March 15, 2012, will not be timely filed. During the performance of Ernst & Young Hua Ming’s audit for the 2011 fiscal year they noted certain inconsistencies. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , | Comments Off

Bioengineering Professor’s Treatment for Shock Under Study

A 200-patient phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by UC San Diego bioengineering Professor Geert Schmid-Schnbein. The study involves a San Diego startup. This new use of the FDA-approved drug is based on decades of research by Schmid-Schnbein on the microvascular and cellular reactions that lead to multi-organ failure after a patient has gone into shock, which is the second-leading cause of in-hospital deaths in the United States. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , | Comments Off

Graduate school programs at UC San Diego, two other major San Diego universities, fared well in U.S. News & World …

City News Service UC San Diegos biomedical/bioengineering program ranked fourth nationally behind Johns Hopkins, Georgia Tech and Duke. The engineering school overall was 14th. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , | Comments Off

Solving Climate Change By Bioengineering Humans?

Join Log In Submit Story Jobs Newsletter Library Library Newsletter Jobs 30334639 story Posted by Soulskill on Monday March 12, @05:13PM from the just-lazy-enough-to-work dept. derekmead writes “Forget CFLs, hybrid cars, and organic jeans. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , | Comments Off

Homing in a life-saving treatment for shock

SAN DIEGO A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego, bioengineering professor Geert Schmid-Schnbein. Conditions expected to qualify for the study include new-onset sepsis and septic shock, post-operative complications and new-onset gastrointestinal bleeding Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , , , | Comments Off

InflammaGen™ Therapeutics to Commence Phase 2 Pilot Study of InflammaGen Shok-Pak

SAN DIEGO, March 12, 2012 /PRNewswire/ –InflammaGen Therapeutics, a development-stage, critical care company initially focused on the diagnosis, treatment and prevention of multi-organ failure (MOF), announced today that the Company has initiated a 200-patient Phase 2 pilot study to examine the efficacy and safety of InflammaGen Shok-Pak as a potential treatment for critically ill patients in the Intensive Care Unit (ICU). Conditions expected to qualify for the study include new-onset sepsis and septic shock, post-operative complications and new-onset gastrointestinal bleeding. The InflammaGen Shok-Pak is the result of decades of research by University of California, San Diego Bioengineering Professor Geert Schmid-Schonbein on the microvascular and cellular reactions that lead to organ failure after a patient has gone into shock, which is the second-leading cause of in-hospital deaths in the United States. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , | Comments Off

InflammaGen to initiate Phase 2 study of new drug/delivery platform for shock

A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Sch-nbein. Conditions expected to qualify for the study include new-onset sepsis and septic shock, post-operative complications, and new-onset gastrointestinal bleeding Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , , , | Comments Off

A lifetime of research may be leading to a life-saving treatment for shock

Public release date: 12-Mar-2012 [ | E-mail | Share ] Contact: Catherine Hockmuth chockmuth@ucsd.edu 858-822-1359 University of California – San Diego A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Schnbein. Conditions expected to qualify for the study include new-onset sepsis and septic shock, post-operative complications, and new-onset gastrointestinal bleeding. This new use of a Food and Drug Administration-approved drug is based on decades of research by Schmid-Schnbein on the microvascular and cellular reactions that lead to multi-organ failure after a patient has gone into shock, which is the second-leading cause of in-hospital deaths in the United States Continue reading

Posted in BioEngineering | Tagged , , , , , , , | Comments Off

Students vie for cheaper on-campus dining

by: Tyler North on March 9, 2012 Students have diverse opinions when it comes to eating on campus. However, most students agree on one aspect of on-campus dining its expensive. Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , | Comments Off

University of Maryland Announces 28 Semifinalists for UMD $75K Business Plan Competition

To: EDUCATION AND NATIONAL EDITORS COLLEGE PARK, Md., March 8, 2012 /PRNewswire-USNewswire/ — The University of Maryland today announces 28 faculty, student and alumni semifinalist teams for the twelfth annual UMD $75K Business Plan Competition. The competition, fostering university startups for over a decade, has spurred companies such as Squarespace, Lurn, AnthroTronix, Alertus Technologies, RioRey (then MacroPhage), Remedium Technologies, FlexEl, Resensys and Traffax Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , | Comments Off

Development of new-generation solar cells

Researchers from The University of Queensland (UQ) and Korea have combined their expertise in polymer patterning and materials science in a bid to develop new-generation solar cells. UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) Director, Professor Peter Gray, has signed a memorandum of understanding with Yonsei University in Seoul, Korea. It will allow AIBN Professor Ajayan Vinu’s research group to work closely with Yonsei Department of Chemical and Biomolecular Engineering, Professor Eunkyoung Kim, and School of Advanced Materials Science and Engineering, Professor Cheolmin Park Continue reading

Posted in BioEngineering | Tagged , , , , , , , , , , , , , , | Comments Off